These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 22396326)
1. Re: usefulness of dynamic urethral resistance relation (DURR) measurement for differential diagnosis between static and dynamic urinary obstruction in male spinal cord injury patients. Neurourol urodyn 2012;31:549-55. Rosier PF Neurourol Urodyn; 2012 Apr; 31(4):556. PubMed ID: 22396326 [No Abstract] [Full Text] [Related]
2. Usefulness of Dynamic Urethral Resistance Relation (DURR) measurement for differential diagnosis between static and dynamic urinary obstruction in male spinal cord injury patients. Vírseda M; Salinas J; López A; Esteban M Neurourol Urodyn; 2012 Apr; 31(4):549-55. PubMed ID: 22396315 [TBL] [Abstract][Full Text] [Related]
3. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Kaplan SA J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031 [No Abstract] [Full Text] [Related]
4. Differentiation between neurogenic and prostatic obstruction using the intraprostatic spiral. A case report. Ovesen H; Poulsen AL; Nordling J Scand J Urol Nephrol; 1990; 24(3):179-80. PubMed ID: 1700470 [TBL] [Abstract][Full Text] [Related]
5. Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury? Schurch B; Schmid DM; Karsenty G; Reitz A Urology; 2005 Feb; 65(2):243-6. PubMed ID: 15708030 [TBL] [Abstract][Full Text] [Related]
8. [Use of uroflowmetry as a method of evaluating obstruction of the lower urinary tract]. Minkov N; Kunchev S; Deliĭski P; Gotsev G Khirurgiia (Sofiia); 1983; 36(6):551-6. PubMed ID: 6199550 [No Abstract] [Full Text] [Related]
15. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia. van Venrooij GE; Eckhardt MD; Boon TA Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441 [TBL] [Abstract][Full Text] [Related]
16. [Usefulness of DURR (dynamic urethral resistance factor) in the study of prostatism]. Salinas Casado J; Aristizabal Agudelo JM; Virseda Chamorro M; Esteban Fuertes M; Resel Estévez L Arch Esp Urol; 1996 May; 49(4):405-12. PubMed ID: 8754196 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic scale of infravesical obstruction in patients d with benign prostatic hyperplasia]. Aboian IA; Golovko SIu; Khitar'ian AG; Levin EG; Pavlov SV Urol Nefrol (Mosk); 1998; (6):32-7. PubMed ID: 10051826 [TBL] [Abstract][Full Text] [Related]
18. [Pharmaco-profilometry using alpha-1a adrenergic blockers in the diagnosis of dynamic infravesical obstruction in the vesicourethral zone segment]. Mazo EB; Chepurov AK; Krivoborodov GG; Tarasova EV; Malenko VP Urol Nefrol (Mosk); 1998; (6):21-4. PubMed ID: 10051822 [TBL] [Abstract][Full Text] [Related]
19. Obstructive voiding symptoms secondary to prostate disease. American College of Radiology. ACR Appropriateness Criteria. Bluth EI; Amis ES; Bigongiari LR; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA Radiology; 2000 Jun; 215 Suppl():693-6. PubMed ID: 11037486 [No Abstract] [Full Text] [Related]
20. Routine bladder biopsies in men with bladder outlet obstruction? Horn T; Kortmann BB; Holm NR; Smedts F; Nordling J; Kiemeney LA; de la Rosette JJ Urology; 2004 Mar; 63(3):451-6. PubMed ID: 15028436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]